Similarly, in a model of allergic airway inflammation induced by Timothy grass pollen extract, the administration of MALP-2 (TLR2/6 agonist) during the allergen challenge reduced eosinophilic inflammation and IL-5 and IL-10 production by lymph nodes [18]. The gene discussed is IL5; the disease is inflammation.